Q: Why are psychedelic drugs suddenly being called medicine with billion-dollar markets? Aren’t they still illegal?

A: Yes, for almost everyone. But the people writing the rules have started calling them medicine, and in our culture that word aligns with therapies, clinicians, illnesses and injuries. Words have power, and in this case, medicine carries the power of influence, priority and money.
The Controlled Substances Act of 1970 put LSD, psilocybin, mescaline, DMT, ibogaine and cannabis in Schedule I, a category defined by “no currently accepted medical use,” and the drug war followed. Now, practically overnight, they are gaining legitimacy as medicine: used, studied, modified, copied, trademarked and valued for one industry only, while people are still serving life sentences for non-violent psychedelic offenses.
The Western understanding of medicine is narrow. In many Indigenous traditions, medicine means something far larger than treatment. It’s the energy, spirit and relationship found in everything: plants, sound, movement, words, the ways everything is connected. Those are all medicine. Medicines have intelligence, spirit, energetic charge. They give us gifts, insights and value far beyond simply healing.
Ceremonial uses, some of them ancient, still have almost no legal standing. State-regulated plans are few, small and still federally illegal, so they have restrictions on insurance coverage, banking, taxation and so many other things.
I work with psychedelics as a practitioner, and the people I work with are not sick or broken. What they come seeking goes beyond what ails them. Even when they seek true, physical healing, they receive far more. These are not medical experiences, or medical results, as we understand the word.
But the truth is, most psychedelic experiences do not happen in a research, clinical or religious setting. They happen around music, art, movement, nature and connection: festivals, private and intimate gatherings, moments of transcendence. I hate to break it to you, but that is ceremony, practiced in our day-to-day lives. These substances are fundamentally ceremonial, and some, such as iboga and ayahuasca, have been strictly ceremonial for centuries. And now, through the power of words, they are being gifted, part and parcel, to the medicalized industrial complex.
And my industry’s dirty secret is that at the big trade conferences, top presenters on policy, ethics and research use the same substances they want to gatekeep, profit from and control, at a fraction of the cost and without any legal, bureaucratic or diagnostic hurdles and hoops to jump through, to find healing at the after-parties. But those spaces are infused with the cleanest, most sacred substances, beautiful music, works of art, play, connection and dancing: all of that is closer to the true meaning of “medicine” than what is even represented on the stage.
Follow the money. The Drug Enforcement Agency lets registered researchers and manufacturers handle Schedule I substances, which is the first step toward asking the Food and Drug Administration for permission to sell, and no other industry gets that door. Ketamine offers a preview. Compounded ketamine and clinic infusions typically cost a few hundred dollars a session. Spravato, Johnson & Johnson’s patented version, runs roughly $600 to $1,600 a session before insurance. Full treatment schedules cost upward of $60k for many months of treatment. Insurance picks up that bill, but we all pay it through our premiums.
Ceremonies and spirituality, even Burning Man and mega churches, are not pulling in that kind of money. So these substances are suddenly medicine.
Pharma would like to take away your right to a lifelong relationship with the sacred and connection to the divine mysteries through what grows freely from the earth, strip it down into a clinical experience with as little comfort and ceremony as ethically possible, and price it into a once-in-a-lifetime opportunity.
You cannot own a plant, but you can own a formulation: Compass Pathways holds patents on a form of synthetic psilocybin. When it costs thousands and requires a lab to synthesize it, we let people have it. Everyone else is treated like fiends and criminals. To get through the medical door, you have to be sick, damaged or close enough to death to deserve it. Be grieving, curious, confused, seeking or standing at a threshold, and you just haven’t earned it yet, baby!
Some developers are building psychedelics without the psychedelic part, so a pill can be taken at home with no costly support or hours of supervision. Who the heck asked for that? Insurance companies?
The difference between ceremony and commerce is reciprocity and restraint versus entitlement and extraction. That is why these things are suddenly gaining traction as medicine: who holds power and control, who profits and who is still excluded from the table.
โThis column is for educational purposes and isn’t a substitute for medical or legal advice. Questions are encouraged. Please send them to Mary@Myco.Vision and they may be answered in future columns.







